Megalin dependent urinary cystatin C excretion in ischemic kidney injury in rats

PLoS One. 2017 Jun 2;12(6):e0178796. doi: 10.1371/journal.pone.0178796. eCollection 2017.

Abstract

Background: Cystatin C, a marker of kidney injury, is freely filtered in the glomeruli and reabsorbed by the proximal tubules. Megalin and cubilin are endocytic receptors essential for reabsorption of most filtered proteins. This study examines the role of these receptors for the uptake and excretion of cystatin C and explores the effect of renal ischemia/reperfusion injury on renal cystatin C uptake and excretion in a rat model.

Methods: Binding of cystatin C to megalin and cubilin was analyzed by surface plasmon resonance analysis. ELISA and/or immunoblotting and immunohistochemistry were used to study the urinary excretion and tubular uptake of endogenous cystatin C in mice. Furthermore, renal uptake and urinary excretion of cystatin C was investigated in rats exposed to ischemia/reperfusion injury.

Results: A high affinity binding of cystatin C to megalin and cubilin was identified. Megalin deficient mice revealed an increased urinary excretion of cystatin C associated with defective uptake by endocytosis. In rats exposed to ischemia/reperfusion injury urinary cystatin C excretion was increased and associated with a focal decrease in proximal tubule endocytosis with no apparent change in megalin expression.

Conclusions: Megalin is essential for the normal tubular recovery of endogenous cystatin C. The increase in urinary cystatin C excretion after ischemia/reperfusion injury is associated with decreased tubular uptake but not with reduced megalin expression.

MeSH terms

  • Animals
  • Cystatin C / urine*
  • Ischemia / urine*
  • Kidney / blood supply*
  • Low Density Lipoprotein Receptor-Related Protein-2 / physiology*
  • Male
  • Mice
  • Mice, Transgenic
  • Protein Binding
  • Rats
  • Rats, Wistar

Substances

  • Cystatin C
  • Low Density Lipoprotein Receptor-Related Protein-2

Grants and funding

The Danish Medical Research Council, The Novo-Nordisk Foundation, The Lundbeck Foundation, and Fonden til Lægevidenskabens Fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.